Search
for
Sort by
Research 121–150 of 124
- Myo-Inositol (ProFecund Ino) – Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome
- Central precocious puberty secondary to peripheral precocious puberty due to a pineal germ cell tumor: a case and review of literature
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Hormonal manipulation of benign prostatic hyperplasia
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Chapter 23. Therapeutic Control of Androgen Action
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Androgen antagonists in androgen target tissues
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Polyzystisches Ovar-Syndrom (PCOS)
- Redefining hormone resistance in prostate cancer
- Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- News & Notes
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Clinical applications of antiandrogens
- Cardiovascular effects of hormone therapy for prostate cancer
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Chapter 17. Selective androgen receptor modulators (SARMs)
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels